Trump’s Executive Order Expediting Ibogaine Research: A Historic Move for Mental Health
President Trump signed an executive order directing the FDA to expedite the review of ibogaine and other psychedelics aimed at treating mental health disorders.
President Trump signed an executive order directing the FDA to expedite the review of ibogaine and other psychedelics aimed at treating mental health disorders.